Trademark Overview
On Wednesday, December 24, 2025, a trademark application was filed for COLLABIQ with the United States Patent and Trademark Office. The USPTO has given the COLLABIQ trademark a serial number of 99564811. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, May 6, 2026. The COLLABIQ trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Downloadable software for biomedical knowledge graph construction, graph machine learning, and life sciences data interoperability; downloadable software for integrating multi-modal life sciences data, namely, genomic, transcriptomic, proteomic, clinical trial, real-world evidence, publication, patent, pharmacology, safety, and regulatory data for small molecule, biologic, and biotherapeutic development, namely, antibody therapeutics, cell and gene therapies, and immunotherapies; downloadable artificial intelligence software for target identification, biomarker discovery, drug repositioning, toxicology prediction, adverse event prediction, disease subtyping, patient stratification, clinical trial design, competitive intelligence, health economics, and health analytics; downloadable software, classified as a Software as a Medical Device (SaMD), for clinical decision support providing link prediction and evidential association between patient-specific genomic variants, clinical phenotype...
Software as a services (SaaS) featuring a knowledge graph computer software platform for life sciences data interoperability, integration, and link prediction; platform as a services (PaaS) featuring a computer software platform for biomedical entity resolution and semantic data harmonization; providing temporary use of non-downloadable cloud-based software for competitive intelligence, patient journey analysis, population health analytics, real-world evidence generation, and clinical research applications; providing temporary use of non-downloadable artificial intelligence software featuring probabilistic knowledge graph analysis and automated hypothesis generation for novel therapeutic target validation; scientific data analysis services for drug discovery, precision medicine, companion diagnostic development, and health economics and outcomes research, namely, scientific consulting services in the field of clinical trial simulation and patient response prediction based on integr...
